MedTrace Logo

IORT Versus CCRT for Pancreatic Cancer

NCT02981641 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-12-05

No results posted yet for this study

Summary

The purpose of this study is to find the better radiation therapy between intraoperative radiotherapy (IORT) and concurrent chemoradiotherapy (CCRT).

Conditions

  • Pancreatic Cancer Stage IV

Interventions

RADIATION

Intraoperative radiotherapy (IORT)

Total dose: 18\~22 Gy; Single dose: 18\~22 Gy; Frequency: 1

DRUG

Sequential chemotherapy

Sequential chemotherapy

RADIATION

Three dimensional conformal radiation therapy (3D-CRT)

Total dose: 60 Gy; Single dose: 2 Gy; Frequency: 30

DRUG

Concurrent chemotherapy

Gemcitabine (GEM), 800 mg/m2 weekly on Day 1-21, Q28d; or S-1 orally, 400 mg/d, bid on Day 1-21, Q28d

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Chengfeng Wang, B.A. · Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02981641 on ClinicalTrials.gov